Bridgeway Capital Management’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,116
| Closed | -$55.7K | – | 1382 |
|
|
2023
Q4 | $55.7K | Hold |
4,116
| – | – | ﹤0.01% | 1304 |
|
|
2023
Q3 | $98.4K | Hold |
4,116
| – | – | ﹤0.01% | 1234 |
|
|
2023
Q2 | $129K | Sell |
4,116
-711
| -15% | -$22.3K | ﹤0.01% | 1215 |
|
|
2023
Q1 | $113K | Hold |
4,827
| – | – | ﹤0.01% | 1214 |
|
|
2022
Q4 | $93.7K | Hold |
4,827
| – | – | ﹤0.01% | 1228 |
|
|
2022
Q3 | $95K | Hold |
4,827
| – | – | ﹤0.01% | 1282 |
|
|
2022
Q2 | $98K | Hold |
4,827
| – | – | ﹤0.01% | 1228 |
|
|
2022
Q1 | $145K | Hold |
4,827
| – | – | ﹤0.01% | 1222 |
|
|
2021
Q4 | $185K | Hold |
4,827
| – | – | ﹤0.01% | 1171 |
|
|
2021
Q3 | $160K | Sell |
4,827
-2,133
| -31% | -$70.7K | ﹤0.01% | 1221 |
|
|
2021
Q2 | $379K | Sell |
6,960
-1,706
| -20% | -$92.9K | 0.01% | 1147 |
|
|
2021
Q1 | $494K | Buy |
8,666
+2,844
| +49% | +$162K | 0.01% | 1087 |
|
|
2020
Q4 | $311K | Hold |
5,822
| – | – | 0.01% | 1112 |
|
|
2020
Q3 | $166K | Buy |
5,822
+1,421
| +32% | +$40.5K | ﹤0.01% | 1197 |
|
|
2020
Q2 | $147K | Buy |
+4,401
| New | +$147K | ﹤0.01% | 1194 |
|
|
2020
Q1 | – | Sell |
-684
| Closed | -$44K | – | 1366 |
|
|
2019
Q4 | $44K | Hold |
684
| – | – | ﹤0.01% | 1281 |
|
|
2019
Q3 | $47K | Hold |
684
| – | – | ﹤0.01% | 1276 |
|
|
2019
Q2 | $88K | Hold |
684
| – | – | ﹤0.01% | 1253 |
|
|
2019
Q1 | $97K | Hold |
684
| – | – | ﹤0.01% | 1281 |
|
|
2018
Q4 | $72K | Buy |
+684
| New | +$72K | ﹤0.01% | 1326 |
|